Nippon India Pharma Fund vs Tata India Pharma & Healthcare Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹7404 Cr | ₹949 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 01 Jun 2004 | 28 Dec 2015 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | Nifty Pharma TRI |
| Turn Over | 21% | 26.49% |
| Expense Ratio | 1.82 | 2.21 |
| Manager | Sailesh Raj Bhan | Meeta Shetty |
| ISIN Code | INF204K01968 | INF277K016A9 |
| Exits Load | Exit load of 1% if redeemed within 1 month./365 | Exit load of 0.25% if redeemed within 30 days./365 |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Month | -4.56% | -5.29% |
| 6 Month | 14.93% | 15.76% |
| 1 Year | 34.98% | 39.2% |
| 3 Year | 18.23% | 19.22% |
| 5 Year | 26.92% | 26.04% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 31.44% | 34.35% |
| 3 Year | 30.78% | 31.62% |
| 5 Year | 25.57% | 25.67% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Year | 17.79% | 6.67% |
| 3 Year | 20.87% | 17.46% |
| 5 Year | 20.18% | 14.22% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Standard Deviation | 14.36% | 14.23% |
| Sharp | 0.68% | 0.74% |
| Beta | 0.91% | 0.9% |
| Alpha | 1.57% | 2.85% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Name | Sailesh Raj Bhan | Meeta Shetty |
| Total AUM | ₹96086 Cr | ₹17847 Cr |
| Fund Manage | 5 | 5 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 4.4 | 5.34 |
| Large Cap | 45.96 | 38.65 |
| Mid Cap | 27.12 | 39.68 |
| Small Cap | 22.52 | 16.33 |
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 4.4 | 3.05 |
| Pharmaceuticals & Biotechnology | 75.86 | - |
| Healthcare Services | 17.38 | - |
| Retailing | 2.36 | - |
| Healthcare | - | 93.35 |
| Chemicals | - | 1.31 |
| Services | - | 2.29 |
Top Comparisons
Motilal Oswal Nifty Smallcap 250 Index - Regular Plan
3Y Returns19.8%
UTI Nifty Next 50 Index Fund - Regular Plan - Growth Option
3Y Returns15.76%
Aditya Birla Sun Life Frontline Equity Fund-Growth
3Y Returns12.54%
UTI - Master Share-Growth Option
3Y Returns8.53%
HDFC Gilt Fund - Growth Plan
3Y Returns5.41%
SBI Magnum Gilt Fund - Regular Plan - Growth
3Y Returns6.69%
Aditya Birla Sun Life Equity Savings Fund - Regular Plan - Growth
3Y Returns5.41%
Axis Equity Savings Fund - Regular Plan - Growth
3Y Returns7.5%